They suppress ATM catalytic activity in cancer cells and animal models and have shown strong potentiation of the antitumor activity of ionizing radiation and DSB-inducing chemotherapeutic agents offering possible new combination partners for cancer therapy [30]. The gene discussed is ATM; the disease is cancer.